Neil Brewis
2019
In 2019, Neil Brewis earned a total compensation of $500.1K as Chief Scientific Officer at F-star Therapeutics.
Compensation breakdown
| Bonus | $31,250 |
|---|---|
| Option Awards | $236,408 |
| Salary | $229,587 |
| Other | $2,867 |
| Total | $500,112 |
Brewis received $236.4K in option awards, accounting for 47% of the total pay in 2019.
Brewis also received $31.3K in bonus, $229.6K in salary and $2.9K in other compensation.
Rankings
In 2019, Neil Brewis' compensation ranked 11,766th out of 13,971 executives tracked by ExecPay. In other words, Brewis earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,766 out of 13,971 | 16th |
Division Manufacturing | 4,767 out of 5,698 | 16th |
Major group Chemicals And Allied Products | 1,880 out of 2,197 | 14th |
Industry group Drugs | 1,620 out of 1,883 | 14th |
Industry Pharmaceutical Preparations | 1,201 out of 1,395 | 14th |
Source: SEC filing on April 7, 2021.
Brewis' colleagues
We found six more compensation records of executives who worked with Neil Brewis at F-star Therapeutics in 2019.
2019
Eliot Forster
F-star Therapeutics
Chief Executive Officer
2019
Martin Driscoll
F-star Therapeutics
Chief Executive Officer
2019
Jonathan Freve
F-star Therapeutics
Chief Financial Officer
2019
RP Iyer
F-star Therapeutics
Chief Scientific Officer
2019
Darlene Deptula-Hicks
F-star Therapeutics
Chief Financial Officer
2019
Louis Kayitalire
F-star Therapeutics